Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects

by Tandakha N. Dieye, Birahim P. NDiaye, Alle B. Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A. Diaw, Coumba Toure-Kane, Papa S. Sow, Souleymane Mboup, Helen McShane
Published 2013-01-01

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.

by Tandakha N Dieye, Birahim P Ndiaye, Alle B Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A Diaw, Coumba Toure-Kane, Papa S Sow, Souleymane Mboup, Helen McShane
Published 2013-01-01

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.

by Tandakha N. Dieye, Birahim P. NDiaye, Alle B. Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A. Diaw, Coumba Toure-Kane, Papa S. Sow, Souleymane Mboup, Helen McShane
Published 2013-01-01